RxDoctor Payments Data

George Monir, MD

Clinical Cardiac Electrophysiology · Orlando, FLNPI 1588661136

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $52,750 of the $70,260 with a category attached, or 75.1%. 8 manufacturers reported payments, led by Medical Device Business Services, Inc. at 41.5% of the total.

$70,260in general payments, 2019–2025

Across 75 payments — averaging $936.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$29K
  • Biosense Webster, Inc.$22K
  • Medtronic$15K
  • Altathera Pharmaceuticals LLC$2K
  • Abbott$2K
  • Cardiofocus, Inc.$213
  • plus $178 from 2 others
$418,153in research payments, 2019–2025

Across 67 payments — averaging $6241.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$206K
  • Biosense Webster, Inc.$171K
  • Medtronic$41K

What the payments were for

  • Consulting fees$52,75075%
  • Speaking & faculty fees$2,1003%
  • Travel & lodging$12,94418%
  • Food & beverage$2,4664%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medical Device Business Services, Inc.11$29,150
Biosense Webster, Inc.25$22,035
Medtronic(2 entities)17$14,761
Altathera Pharmaceuticals LLC2$2,056
Abbott17$1,868
Cardiofocus, Inc.1$213
Boston Scientific1$153
Stereotaxis Inc1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$70,260 in reported general payments places this provider in the 80th percentile of 249 clinical cardiac electrophysiology providers in Florida.

See all clinical cardiac electrophysiology providers in Florida

Medicare billing

Part B allowed, 2024
$576,802
Medicare patients
962
Services billed
5,757

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban382$468,273
MultaqDronedarone Hcl163$217,965
XareltoRivaroxaban74$69,683
Dofetilide208$39,144
EntrestoSacubitril/Valsartan14$18,126
SotalolSotalol Hcl179$3,191
Metoprolol Succinate196$2,942
Flecainide Acetate75$2,674
Amiodarone Hcl122$2,260
Ranolazine ErRanolazine11$1,353
Mexiletine Hcl17$1,261
Rosuvastatin Calcium87$950
Losartan Potassium75$854
Clonidine18$853
Carvedilol89$664

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →